Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chambers

Showing results (381-390 of 520) with videos related to

Pageof 52
Sort By:
Clinical Biochemistry|June 1, 1996
Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal womenD S Bautista, Z Saad, A F Chambers, et al.
International Journal of Cancer|July 15, 1990
Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblastsA M Craig, G T Bowden, A F Chambers, et al.
Cancer Research|May 16, 2000
Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiencyM D Cameron, E E Schmidt, N Kerkvliet, et al.
Microbiology Spectrum|April 27, 2023
Role of the NaHCO<sub>3</sub> Transporter MpsABC in the NaHCO<sub>3</sub>-β-Lactam-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureusSook-Ha Fan, Richard A Proctor, Selvi C Ersoy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2009
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureusMin Li, Binh An Diep, Amer E Villaruz, et al.
International Journal of Oncology|October 17, 1998
Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient miceD J van Meyel, O H Sanchez-Sweatman, N Kerkvliet, et al.
Human Pathology|September 1, 1996
The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancerF P O'Malley, Z Saad, N Kerkvliet, et al.
International Journal of Cancer|October 7, 1998
Osteopontin expression in a group of lymph node negative breast cancer patientsA B Tuck, F P O'Malley, H Singhal, et al.
Journal of Cellular Biochemistry|April 13, 2000
Antibodies to different peptides in osteopontin reveal complexities in the various secreted formsS Kon, M Maeda, T Segawa, et al.
Microbiology and Immunology|June 1, 2000
The role of osteopontin in the development of granulomatous lesions in lungS Chiba, M M Rashid, H Okamoto, et al.
Pageof 52

Showing results (381-390 of 520) with videos related to

Sort By:
Pageof 52
Clinical Biochemistry|June 1, 1996
Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal womenD S Bautista, Z Saad, A F Chambers, et al.
International Journal of Cancer|July 15, 1990
Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblastsA M Craig, G T Bowden, A F Chambers, et al.
Cancer Research|May 16, 2000
Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiencyM D Cameron, E E Schmidt, N Kerkvliet, et al.
Microbiology Spectrum|April 27, 2023
Role of the NaHCO<sub>3</sub> Transporter MpsABC in the NaHCO<sub>3</sub>-β-Lactam-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureusSook-Ha Fan, Richard A Proctor, Selvi C Ersoy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2009
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureusMin Li, Binh An Diep, Amer E Villaruz, et al.
International Journal of Oncology|October 17, 1998
Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient miceD J van Meyel, O H Sanchez-Sweatman, N Kerkvliet, et al.
Human Pathology|September 1, 1996
The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancerF P O'Malley, Z Saad, N Kerkvliet, et al.
International Journal of Cancer|October 7, 1998
Osteopontin expression in a group of lymph node negative breast cancer patientsA B Tuck, F P O'Malley, H Singhal, et al.
Journal of Cellular Biochemistry|April 13, 2000
Antibodies to different peptides in osteopontin reveal complexities in the various secreted formsS Kon, M Maeda, T Segawa, et al.
Microbiology and Immunology|June 1, 2000
The role of osteopontin in the development of granulomatous lesions in lungS Chiba, M M Rashid, H Okamoto, et al.
Pageof 52